Murphy Canyon Acquisition Corp.
Status: Deal Closed
U=S+W
W=S@11.50
| IPO Proceeds, $M | $132.25M |
|---|---|
| IPO Date | Feb 3, 2022 |
| CEO | Jack K. Heilbron |
| Left Lead | A.G.P |
| IPO Cash in Trust | 102.0% |
| SPAC Tenor | 12 + 12 |
| IPO Sector |
Real Estate
Businesses in the real estate industry, including construction, homebuilding, real estate owners and operators, arrangers of financing, insurance, and other services for real estate, and adjacent businesses and technologies targeting the real estate space (referred to as PropTech) |
| IPO Geography | Global |
| Target Company | Conduit Pharmaceuticals |
| Deal Announced | Nov 8, 2022 |
| Deal Size, $M | $716.55M |
| Deal Sector | Healthcare |
| Deal Geography | Global |
| SEC Filings | www.sec.gov |
| Approval Vote | Sep 20, 2023 |
| Amendment Vote | Jan 26, 2023 |
| Closing Date | Sep 22, 2023 |
Formerly MURF
CDT
CDTWW
| Price | $0.09 |
|---|---|
| Last closing price | $0.09 |
| H/L, today | $0.09 / $0.10 |
| H/L, 52-week | $0.95 / $12.89 |
| Volume, today | 4,870,379 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Murphy Canyon Acquisition Corp.:
- Structure and cap table
- 6 directors & officers
- 31 filings and events
- 2 underwriters
- 2 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Jack K. Heilbron | 71 | CEO, President, and Chairman |
| Adam Sragovicz | 52 | CFO, Treasurer, and Director |
| Ed Bentzen | 45 | Chief Accounting Officer |
| Francis Knuettel II | 55 | Director |
| Chele Chiavacci Farley | 54 | Director |
| Richard E. Feinberg | 74 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| A.G.P | BR | 6,500,000 | units |
| The Benchmark Company | 5,000,000 | ||
| 11,500,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.